Lv1
20 积分 2025-09-21 加入
A Single Center, Open-label, Randomized Pilot Study to Evaluate the Safety and Efficacy of Tacrolimus Modified Release, ADVAGRAF, Versus Tacrolimus Twice Daily, PROGRAF, in Stable Renal Recipients (SINGLE)
1个月前
已完结
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen
1个月前
已完结
A randomized, open‐label pharmacokinetic trial of tacrolimus extended‐release dosing in obese de novo kidney transplant recipients
1个月前
已完结
A RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSES THE SAFETY AND EFFICACY OF PROGRAF/MYFORTIC AND ADVAGRAF/MYFORTIC IN DE NOVO LIVER TRANSPLANT RECIPIENTS— A PRELIMINARY REPORT
1个月前
已完结
不同CYP3A5基因型受者肾移植术后早期使用不同剂型他克莫司后血药浓度的特点
1个月前
已完结
Lysosome-mediated aggregation of galactose-deficient IgA1 with transferrin receptor 1 links to IgA nephropathy
11个月前
已完结
Quantitative Characterization of Micro-Structure and CO2-Brine Seepage Simulation Based on the Reconstructed Digital Core
皖公网安备34019202002308
